Norrington Lorrie M reported option exercise involving 4,170 derivative units of COLGATE PALMOLIVE CO at $0.00 for $0 on Nov 5, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Nov 9, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
4,170Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 5, 2026Option exercise
Filed
Nov 9, 2026, 4:03 PM ET4-day reporting delay
Accession
0001225208-26-008777Code M · Transaction 395752
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Option exercise4,170$71.56$298,405.20Trade 395750
Nov 5, 2026Sell4,170$99.31−$414,123.12Trade 395751
3 transaction rows in this filing. Joint filers share the same rows.

CL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −9.6%1w ago −3.5%1d ago −1.3%
Returns since7d30d90d180d1y

Footnotes in full

F1: Exercise of stock options awarded under the issuer's incentive compensation plan. F2: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. F3: Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2019 grant date.